| Autor: |
Gretchen M. Ray, Chelsea Rodriguez, Samantha M. Schulman, Preeyaporn Sarangarm, Michelle Bardack, Matthew F. Bouchonville |
| Jazyk: |
angličtina |
| Rok vydání: |
2019 |
| Předmět: |
|
| Zdroj: |
Clinical Practice and Cases in Emergency Medicine, Vol 3, Iss 2 (2019) |
| Druh dokumentu: |
article |
| ISSN: |
2474-252X |
| DOI: |
10.5811/cpcem.2019.2.41795 |
| Popis: |
Empagliflozin is a sodium glucose cotransporter-2 inhibitor that inhibits renal glucose reabsorption through an insulin-independent mechanism. This class of drugs is used in the management of type 2 diabetes. A 49-year-old female with type 2 diabetes treated with empagliflozin presented to the emergency department in diabetic ketoacidosis (DKA). This case report details the series of events leading to the diagnosis of drug-induced DKA, which led to a change in the patient’s diagnosis from type 2 diabetes to type 1 diabetes. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
